Effect of Gabaergic and Glutamatergic Drugs Injected into the Ventral Pallidum on Locomotor Activity

  • Lane J. Wallace
  • Norman J. Uretsky
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 295)


There has been a great deal of recent interest in elucidating the behavioral role of the basal forebrain in cognitive function (Alheid and Heimer, 1988). The ventral pallidum, a part of the basal forebrain, has received a great deal of attention because of the relationship between the degeneration of neurons in this region and the symptoms of cognitive dysfunction associated with Alzheimer’s disease (Whitehouse et al., 1983; Coyle et al., 1983; Ezrin-Waters and Resch, 1986; Smith, 1988). However the ventral pallidum has also been implicated in other functions. Thus, the results of several studies have suggested that the ventral pallidum plays an important role in the regulation of movement or locomotion. This hypothesis is supported by the observations that specific neurotransmitters injected into the ventral pallidum markedly affect normal locomotion (Scheel-Kruger, 1983, 1986; Baud et al., 1988) and the locomotor stimulation produced by drugs that act on neurons in the nucleus accumbens (Mogenson et al., 1980; Heimer et al., 1982; Mogenson and Nielsen, 1983; Swerdlow et al., 1986; Mogenson, 1987; Swerdlow et al., 1986; Austin and Kalivas, 1988). In this chapter we will review these studies and report on our work indicating that quisqualic acid receptors in the ventral pallidum are involved in the regulation of locomotion induced by psychostimulant drugs.


Locomotor Activity Nucleus Accumbens Excitatory Amino Acid Basal Forebrain Kainic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alheid, G.F. and Heimer, L., 1988, New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, amd corticopetal components of the substantia innominata, Neuroscience, 27:1.PubMedCrossRefGoogle Scholar
  2. Austin, M. and Kalivas, P., 1988, The effect of cholinergic stimulation in the nucleus accumbens on locomotor behavior. Brain Res., 441:209.PubMedCrossRefGoogle Scholar
  3. Baud, P., Mayo, W., Le Moal, M. and Simon, H., 1988, Locomotor hyperactivi ty in the rat after infusion of muscimol and [D-Ala]Met-enkephalin into the nucleus basalis magnocellularis. Possible interaction with central cholinergic projections. Brain Res., 452:203.PubMedCrossRefGoogle Scholar
  4. Churchill, L., Dilts, R.P. and Kalivas, P., 1990, Changes in γ-aminobutyric acid, u-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens. Brain Res., 511:41.PubMedCrossRefGoogle Scholar
  5. Coyle, J., Price, D., and Delong, M., 1983, Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science, 219:1184.PubMedCrossRefGoogle Scholar
  6. Davies, S., McBean, G. and Roberts, P., 1984, A glutamatergic innervation of the nucleus basalis/substantia innominata, Neurosci. Lett., 45:105.PubMedCrossRefGoogle Scholar
  7. Dubois, B., Mayo, W., Agid, Y., Lemoal, M., and Simon, H., 1985, Profound disturbances of spontaneous and learned behaviors following lesions of the nucleus basalis magnocellularis in the rat. Brain Res., 338:249.PubMedCrossRefGoogle Scholar
  8. Ezrin-Waters, C. and Resch, L., 1986, The nucleus basalis of Meynert, Cand. J. Nerosci., 13:8.Google Scholar
  9. Heimer, L., Switzer, R.D. and Hoesen, G., 1982, Ventral striatum and ventral pallidum. Components of the motor system. Trends Neurosci., 5:83.CrossRefGoogle Scholar
  10. Hepler, D. and Lerer, B., 1986, The effect of magnocellular basal forebrain lesions on circadian locomotor activity in the rat, Pharmacol. Biochem. Behav., 25:293.PubMedCrossRefGoogle Scholar
  11. Mogenson, G., Jones, D. and Yim, C.Y., 1980, From motivation to action: Functional interface between the limbic system and the motor system. Prog. Neurobiol,, 14:69.PubMedCrossRefGoogle Scholar
  12. Mogenson, G., 1987, Limbic-motor integration. Prog. Psychobiol. Physiol. Psychol., 12:117.Google Scholar
  13. Mogenson, G. and Nielsen M., 1983, Evidence that an accumbens to subpal lidal GABAergic projection contributes to locomotor activity. Brain Res. Bull., 11:309.PubMedCrossRefGoogle Scholar
  14. Monaghan, D.T. and Cotman, C.W., 1985, Distribution of N-methyl-D-aspartate sensitive L-3H-glutamate binding sites in rat brain. J. Neurosci., 5:2909.PubMedGoogle Scholar
  15. Pijnenburg, A., Honig, W., Van der Heyden, J. and Van Rossum, J.M., 1976, Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur. J. Pharmacol., 35:45.PubMedCrossRefGoogle Scholar
  16. Scheel-Kruger, J., 1983, The GABA receptor and animal behavior, “The GABA Receptors,” S. Enna, ed., The Humana Press, Clifton, New Jersey, p. 215.Google Scholar
  17. Scheel-Kruger, J., 1986, Dopamine-GABA interactions: evidence that GABA transmits, modulates, and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurol. Scand. suppl 107, 73:1.Google Scholar
  18. Shreve, P. and Uretsky, N., 1988, Effect of GABAergic transmission in the subpallidal region on the hypermotility response to the administration of excitatory amino acids and Picrotoxin into the nucleus accumbens, Neuropharmacol., 27:1271.CrossRefGoogle Scholar
  19. Shreve, P. and Uretsky, N., 1989, AMPA, kainic acid, and N-methyl-D-aspar- tic acid stimulate locomotor activity after injection into the substantia innominata/lateral preoptic area, Pharmacol. Biochem. Behav., 34:101.PubMedCrossRefGoogle Scholar
  20. Smith, G., 1988, Animal models of Alzheimer’s disease: experimental cholinergic denervation. Brain Res. Rev., 13:103.CrossRefGoogle Scholar
  21. Supko, D., Hill, R.., Uretsky, N., Miller, D., and Wallace, L., 1990, Substituted 0-tyrosines and quinoxaline-2,3-diones as potential quisqualate analogs. FASEB J., 4:A603.Google Scholar
  22. Swerdlow, N. and Koob, G., 1984, The neural substrates of apomorphine- stimulated locomotor activity. Life Sei., 35:2537.CrossRefGoogle Scholar
  23. Swerdlow, N. and Koob, G., 1985, Seperate neural substrates of the locomo tor-activating properties of amphetamine, heroin, caffeine, and corticotropin releasing factor (CRF) in the rat, Pharmacol. Biochem. Behav., 23:303.PubMedCrossRefGoogle Scholar
  24. Swerdlow, N., Vaccarino, F., Amalric, M. and Koob, G., 1986, The neural substrates for the motor activating properties of psychostimulants: a review of recent findings, Pharmacol. Biochem. Behav., 25:233.PubMedCrossRefGoogle Scholar
  25. Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., and DeLong, M., 1982, Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science, 215:1237.Google Scholar
  26. Willins, D., Wallace, L.J., and Uretsky, N., 1990, The role of excitatory amino acid receptors within the subpallidum in the hypermotility response induced by systemically administered stimulants of locomotor activity. FASEB J., 4:A995.Google Scholar
  27. Wood, P.L. and Richard, J., 1982, GABAergic regulation of the substantia innominata-cortical cholinergic pathway, Neuropharmacol., 21:969.CrossRefGoogle Scholar
  28. Zahm, D.S., Zaborszky, L., Alones, V. and Heimer, L., 1985, Evidence for the coexistence of glutamate decarboxylase and met-enkephalin immunoreac- tivities in axon terminals of rat ventral pallidum. Brain Res., 325:317.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Lane J. Wallace
    • 1
  • Norman J. Uretsky
    • 1
  1. 1.College of PharmacyOhio State UniversityColumbusUSA

Personalised recommendations